6-K filed Aug 5, 2026 at 17:09 ET
Manulife reported strong Q2 2026 results with core earnings of $1.9 billion, up 12% YoY, and EPS of $1.20, up 22% YoY. The company delivered double-digit growth across all three insurance new business metrics (APE sales +21%, new business CSM +16%, NBV +10%), driven by strong momentum in Asia. Core ROE improved to 16.3% from 15.0% a year ago. The filing also announced a long-term care reinsurance transaction expected to close in Q4 2026, which will further reduce the company's risk profile. The results underscore the strength of Manulife's diversified portfolio and disciplined execution on strategic priorities.